Skip to main content

Advertisement

SpringerLink
Log in

Etretinate or cyclosporin-A treatment normalizes the enhanced respiratory burst of polymorphonuclear leukocytes in psoriasis

  • Original Contributions
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Summary

During a therapeutic trial to treat psoriasis with either etretinate or cyclosporin A (CyA) we measured the respiratory burst activity of polymorphonuclear leukocytes (PMN). Six patients received 0.5–0.75 mg/kg etretinate and 14 patients 2.5–5.0 mg/kg CyA over a period of 10 weeks. The extent of psoriasis was graded by the psoriasis area-and-severity index (PASI score). The respiratory burst of PMN isolated from the peripheral blood was measured employing luminol-enhanced chemiluminescence at weeks 0, 3 and 10 and compared with that of 26 healthy control individuals. PMN were stimulated with zymosan particles, aggregated immunoglobulin (aggIg) and concanavalin A (ConA). Both treatment regimens improved psoriasis; at 10 weeks there was an approximate 40% PASI score reduction under etretinate and an 80% improvement under CyA. Before treatment the respiratory burst was abnormally high under stimulation with the three stimuli in patients (p=0.021 to<0.0001). After 3 to 10 weeks PMN activity normalized in all patients and even tended to drop below values correlating with an improvement in skin lesions. We conclude that the elevated respiratory burst of PMN in psoriasis normalizes under treatment with both etretinate and CyA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Adamo S, De Luca LM, Silverman-Jones CS, Yuspa S (1979) Mode of action or retinol. Involvement of glycosylation reaction of cultured mouse epithelial cells. J Biol Chem 254: 3279–3287

    Google Scholar 

  2. Babior BM (1978) Oxygen-dependent microbial killing by phagocytes. N Engl J Med 298: 659–668 and 721–725

    Google Scholar 

  3. Bernard BA, De Luca LM, Hassel JR, Yamada KM, Olden K (1984) Retinoic acid alters the proportion of high mannose to complex type oligosacharides on fibronection secreted by cultured chondrocytes. J Biol Chem 259: 5310–5315

    Google Scholar 

  4. Beursken T, Chang A, van Erp PEJ, van de Kerkhof PCM (1989) Epidermal proliferation and accumulation of polymorphonuclear leukocytes in the psoriatic lesion. Dermatologica 178: 67–72

    Google Scholar 

  5. Bloomfield FJ, Young MM (1982) Enhanced release of inflammatory mediators from lithium-stimulated neutrophils in psoriasis. Br J Dermatol 109: 9–13

    Google Scholar 

  6. Brigelius R (1985) Mixed disulfides: biological functions and increase in oxidative stress. In: Sies H (ed) Oxidative stress. Academic Press, London, pp 243–272

    Google Scholar 

  7. Camisa C, Eisenstat B, Ragaz A, Weissmann G (1982) The effects of retinoids on neutrophil functions in vitro. J Am Acad Dermatol 4: 620–629

    Google Scholar 

  8. Coble B-I, Dahlgren C, Molin L, Stendahl O (1987) Neutrophil function in psoriasis: effects of retinoids. Acta Derm Venereol (Stockh) 67: 481–490

    Google Scholar 

  9. Dahlgren C, Stendahl O (1983) Role of myeloperoxidase in luminol-dependent chemiluminescence of polymorphonuclear leukocytes. Infect Immunol 39: 736–741

    Google Scholar 

  10. Dogan P, Soyuer ü, Tanrikulu G (1989) Superoxide dismutase and myeloperoxidase activity in polymorphonuclear leukocytes, and serum ceruloplasmin and copper levels, in psoriasis. Br J Dermatol 120: 239–244

    Google Scholar 

  11. Dubertret L, Lebreton C, Touraine R (1982) Inhibition of neurophil migration by etretinate and its main metabolite. Br J Dermatol 107: 681–685

    Google Scholar 

  12. Fredriksson T, Petterson U (1978) Severe psoriasis — oral therapy with a new retinoid. Dermatologica 157: 238–244

    Google Scholar 

  13. Geerdink JPM, Troost PW, Schalkwijk J, Joosten LAB, Mier PD (1985) The ‘metabolic burst’ in polymorphonuclear leukocytes from patients with quiescent psoriasis. Br J Dermatol 112: 387–392

    Google Scholar 

  14. Glinski W, Barszcz D, Janczura E, Zarebska Z, Jabłonska S (1984) Neutral proteinases and other neutrophil enzymes in psoriasis, and their relation to disease activity. Br J Dermatol 111: 147–154

    Google Scholar 

  15. Guthrie LA, McPhail L, Henson PM, Johnston RB Jr (1984) Priming of neutrophils for an enhanced release of oxygen metabolites by bacterial lipopolysaccharides. J Exp Med 160: 1656–1671

    Google Scholar 

  16. Hess AD, Colombani PM (1986) Mechanism of action of ciclosporin: in vitro studies. In: Borel JF (ed) Ciclosporin. Prog Allergy, Vol 38. Karger, Basel pp 198–221

    Google Scholar 

  17. Jain VK, Gupta V, Verma KC, Saini AS (1985) NADPH oxidase and myeloperoxidase activity in psoriasis leukocytes. J Dermatol 12: 524–428

    Google Scholar 

  18. Janco RL, English D (1983) Cyclosporine and human neutrophil function. Transplantation 35: 501–506

    Google Scholar 

  19. Juhlin L, Vahlquist C (1983) The influence on treatment of fibrin microclot generation in psoriasis Br J Dermatol 108: 33–37

    Google Scholar 

  20. Kahler S, Christophers E, Schröder J-M (1988) Plasma lactoferrin reflects neutrophil activation in psoriasis. Br J Dermatol 119: 289–293

    Google Scholar 

  21. Kapp A, Schöpf E (1986) Cellular reactivity of polymorphonuclear leukocytes in psoriasis and atopic dermatitis — measurement of lucigenin-dependent chemiluminescence. Acta Derm Venereol (Stockh) 66: 285–289

    Google Scholar 

  22. Kharazmi AM, Svenson M, Nielsen H, Birgens HS (1985) Effect of cyclosporin A on human neutrophil and monocyte function. Scand J Immunol 21: 585–591

    Google Scholar 

  23. Langner A, Chorzelski TP, Franczykowska S, Jabłonska S, Szymanczyk J (1983) Is chemotactic activity of polymorphonuclear leukocytes increased in psoriasis? Arch Dermatol Res 275: 226–228

    Google Scholar 

  24. Lever WF, Schaumburg-Lever G (1983) Histopathology of the skin, 2nd edn JB Lippincott Co., Philadelphia, pp 139–147

    Google Scholar 

  25. Lundin A, Hakansson L, HÄllgren R, Michaelsson G, Venge P (1983) Studies on the phagocytic activity of the granulocytes in psoriasis and palmoplantar pustulosis. Br J Dermatol 109: 539–547

    Google Scholar 

  26. Lundin A, Hakansson L, HÄllgren R, Michaelsson G, Venge P (1985) Increased in vivo secretory activity of neutrophil granulocytes in patients with psoriasis and palmoplantar pustulosis. Arch Dermatol Res 277: 179–184

    Google Scholar 

  27. Majewski S, Jabłonska S, Langner A, Pawinska M, Szmurto A (1985) The adherence to human endothelium and plastic of neutrophils from psoriatic patients, and the effects of psoriatic patients' sera on normal neutrophils. Br J Dermatol 112: 655–662

    Google Scholar 

  28. Paslin D (1990) Psoriasis without neutrophils. Int J Dermatol 29: 37–40

    Google Scholar 

  29. Pigatto PD, Riva F, Altamore GF, Brugo AM, Morandotti A, Finzi AF (1983) Effect of etretinate on chemotaxis of neutrophils from patients with pustular and vulagar psoriasis. J Invest Dermatol 82: 418–419

    Google Scholar 

  30. Preissner WC, Schröder J-M, Christophers E (1983) Altered polymorphonuclear leukocyte responses in psoriasis: chemotaxis and degranulation. Br J Dermatol 109: 1–8

    Google Scholar 

  31. Ruzicka T (1985) Effect of retinoids on arachidonic acid metabolism in human epidermis and polymorphonuclear leukocytes. In: Saurat JH (ed) Retinoids: new trends in research and therapy. Karger, Basel, pp 180–182

    Google Scholar 

  32. Schopf RE, Straussfeld E (1985) Stimulus-dependent increased generation of oxygen intermediates in monocytes and polymorphonuclear leukocytes in psoriasis. J Invest Dermatol 84: 73–76

    Google Scholar 

  33. Schopf RE, Mattar J, Meyenburg W, Scheiner O, Hammann KP, Lemmel E-M (1984) Measurement of the respiratory burst in human monocytes and polymorphonuclear leukocytes by nitro blue tetrazolium reduction and chemiluminescence. J Immunol Methods 67: 109–117

    Google Scholar 

  34. Schopf RE, Ziegler C, Rehder M, Morsches B (1992) Oxidative damage of normal and neoplastic epidermal cells by stimulated polymorphonuclear leukocytes in man. In: Jesaitis AJ, Dratz EA (eds) Molecular basis of oxidative damage by leukocytes. CRC Press, Boca Raton, Fla., 333–335

    Google Scholar 

  35. Schopf RE, Höcher J, Schütz N, FÄrber L, Morsches B (1992) Psoriasis treatment with etretinate versus cyclosporin A — clinical course and serum concentrations of soluble interleukin-2 receptors and CD8 antigen. Eur J Dermatol 2: 224–230

    Google Scholar 

  36. Sedgwick JB, Bergstresser PR, Hurd ER (1980) Increased granulocyte adherence in psoriasis and psoriatic arthritis. J Invest Dermatol 74: 81–84

    Google Scholar 

  37. Sohnle PG, Hahn BL (1989) Epidermal proliferation and the neutrophilic infiltrates of experimental cutaneous candidiasis in mice. Arch Dermatol Res 28: 279–283

    Google Scholar 

  38. Soon-Shiong P, Grewal IS (1988) Enhancement of lectininduced cap formation in human neutrophils by cyclosporin A. Biochem Biophys Res Commun 151: 435–443

    Google Scholar 

  39. Stendahl O, Andersson T, Coble B-I, Dahlgren C, Lew D (1985) Selective modulation of a chemotactic receptor in HL-60 cells by retinoic acid. In: Saurat JH (ed) Retinoids: new trends in research and therapy. Karger, Basel, pp 260–264

    Google Scholar 

  40. Voorhees JJ (1983) Leukotrienes and other lipoxygenase products in the pathogenesis and therapy of psoriasis and other dermatoses. Arch Dermatol 119: 541–547

    Google Scholar 

  41. Wasik F, Jedrezejak J, Miklaszweska M (1987) Granulocyte pyruvate kinase in psoriasis vulgaris and psoriasis arthropathica. Br J Dermatol 116: 9–14

    Google Scholar 

  42. Wenzel-Scifert K, Grünbaum L, Scifert R (1991) Differential inhibition of human neutrophil activation by cyclosporins A, D, and H. J Immunol 147: 1940–1946

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. UniversitÄts-Hautklinik, Langenbeckstrasse 1, W-6500, Mainz, Germany

    R. E. Schopf, J. Höcher, M. Rehder & B. Morsches

  2. Sandoz AG, Nürnberg, Germany

    L. FÄrber

Authors
  1. R. E. Schopf
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Höcher
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Rehder
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. FÄrber
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B. Morsches
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This paper contains data from the doctoral thesis of J. H.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schopf, R.E., Höcher, J., Rehder, M. et al. Etretinate or cyclosporin-A treatment normalizes the enhanced respiratory burst of polymorphonuclear leukocytes in psoriasis. Arch Dermatol Res 284, 227–231 (1992). https://doi.org/10.1007/BF00375799

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00375799

Key words

Search

Navigation